Central and peripheral cannabinoid modulation of gastrointestinal transit in physiological states or during the diarrhoea induced by croton oil

British Journal of Pharmacology

Volumn 129, Issue 8, 2000, Pages 1627-1632

  Izzo, Angelo A ^a   Pinto, Luisa ^a   Borrelli, Francesca ^a   Capasso, Raffaele ^b   Mascolo, Nicola ^b   Capasso, Francesco ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY OF SALERNO   (Italy)

Author keywords

Antidiarrhoeal drugs; Cannabinoid receptors; Inflammatory bowel disease; Intestinal motility; Small intestine

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 5 (4 CHLORO 3 METHYLPHENYL) 1 (4 METHYLBENZYL) N (1,3,3 TRIMETHYLBICYCLO[2.2.1]HEPTAN 2 YL) 3 PYRAZOLECARBOXAMIDE; CANNABINOID; CANNABINOL; CROTON OIL; GANGLION BLOCKING AGENT; HEXAMETHONIUM; RIMONABANT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DIARRHEA; DOSE RESPONSE; GANGLION BLOCK; GASTROINTESTINAL MOTILITY; MALE; MOUSE; NONHUMAN; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL;

EID: 0033995911     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0703265     Document Type: Article

References (36)

1. ALBASAN, H., SOLDANI, G. & BROWN, D.R. (1999). Synthetic cannabinoids potentiate electrically-induced contractions in porcine ileum in vitro. Pharm. Res., 39 (Supplement), 5.
2. CALIGNANO, A., LA RANA, G., MAKRIAYANNIS, A., LIN, S.Y., BELTRAMO, M. & PIOMELLI, D. (1997). Inhibition of intestinal motility by anandamide, an endogenous cannabinoid. Eur. J. Pharmacol., 340, R7-R8.
3. CHESHER, G.B., DAHL, C.J., EVERNGHAM, M., JACKSON, D.M., MARCHANT-WILLIAMS, H. & STARMER, G.A. (1973). The effect of cannabinoids on intestinal motility and their antinociceptive effect in mice. Br. J. Pharmacol., 49, 588-594.
4. COLOMBO, G., AGABIO, R., LOBINA, C., REALI, R. & GESSA, G.L. (1998). Cannabinoid modulation of intestinal propulsion in mice. Eur. J. Pharmacol., 344, 67-69.
5. 9-tetrahydrocannabinol. J. Pharmacol. Exp. Ther., 263, 1118-1126.
6. COUTTS, A.A. & PERTWEE, R.G. (1997). Inhibition by cannabinoid receptor agonists of acetylcholine release from the guinea-pig myenteric plexus. Br. J. Pharmacol., 121, 1557-1566.
7. 1 receptors in human ileum. Br. J. Pharmacol., 125, 1393-1396.
8. DEVANE, W.A., HANUS, L., BREUER, A., PERTWEE, R.G., STEVENSON, L.A., GRIFFIN, G., GIBSON, D., MANDELBAUM, A., ETINGER, A. & MECHOULAM, R. (1992). Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science, 277, 119-131.
9. DEWEY, W.L., HARRIS, L.S. & KENNEDY, J.S. (1972). Some pharmacological and toxicological effects of 1-trans-8 and 1-trans-9tetrahydrocannabinol in laboratory rodents. Arch. Int. Pharmacod. Ther., 196, 133-145.
10. FELDER, C.C. & GLASS, M. (1998). Cannabinoid receptors and their endogenous agonists. Annu. Rev. Pharmacol. Toxicol., 38, 179-200.
11. 2-like cannabinoid receptors on peripheral nerve terminals. Eur. J. Pharmacol., 339, 53-61.
12. HALEY, T.J. & MCCROMICK, W.G. (1957). Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse. Br. J. Pharmacol., 12, 12-15.
13. HEINEMANN, A., SHAHBAZIAN, A. & HOLZER, P. (1999). Cannabinoid inhibition of guinea-pig intestinal peristalsis via inhibition of excitatory and activation of inhibitory neural pathways. Neuropharmacology, 38, 1289-1297.
14. 1 receptor. Br. J. Pharmacol., 124, 1363-1368.
15. 1 receptors. Naunyn-Schmiedeberg's Arch. Pharmacol., 359, 65-70.
16. IZZO, A.A., MASCOLO, N., CAPASSO, R., GERMANO', M.P., DE PASQUALE, R. & CAPASSO, F. (1999b). Inhibitory effect of cannabinoid agonists on gastric emptying in the rat. Naunyn-Schmiedeberg's Arch. Pharmacol., 360, 221-223.
17. IZZO, A.A., MASCOLO, N., PINTO, L., CAPASSO, R. & CAPASSO, F. (1999c). The role of cannabinoid receptors in intestinal motility, defaecation and diarrhoea in rats. Eur. J. Pharmacol., 384, 37-42.
18. 1 ligands in the isolated guinea-pig ileum. Br. J. Pharmacol., 129, 984-990.
19. 9-tetrahydrocannabinol on intestinal motility and on the abdominal constriction response in the mouse. Psychopharmacology, 47, 187-193.
20. 1 receptors. Eur. J. Pharmacol., 334, R1-R2.
21. LOPEZ-REDONDO, F., LEES, G.M. & PERTWEE, R.G. (1997). Effects or cannabinoid receptor ligands on electrophysiological properties of myenteric neurones of the guinea-pig ileum. Br. J. Pharmacol., 122, 330-384.
22. 2 receptors. Br J. Pharmacol., 124, 619-622.
23. MATSUDA, L.A., LOLAIT, S.J., BROWNSTEIN, B.J., YOUNG, A.C. & BONNER, T.L. (1990). Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature, 346, 561-564.
24. MECHOULAM, R., BEN-SHABAT, S., HANUS, L., LIGUMSKY, M., KAMINSKI, N.E., SCHATZ, A.R., GOPHER, A., ALMOG, S., MARTIN, B.R., COMPTON, D.R., PERTWEE, R.G., GRIFFIN, G., BAYEWITCH, M., BARG, J. & VOGEE, Z. (1995). Identification of an endogenous 2-monogliceride, present in canine gut, that binds to a cannabinoid receptor. Biochem. Pharmacol., 50, 83-90.
25. MECHOULAM, R., FRIDE, E. & DI MARZO, V. (1998). Endocannabinoids. Eur. J. Pharmacol., 359, 1-18.
26. MUNRO, S., THOMAS, K.L. & ABU-SHAAR, M. (1993). Molecular characterization of a peripheral receptor for cannabinoids. Nature, 365, 61-65.
27. PERTWEE, R.G. (1998). Pharmacological, physiological and clinical implications of the discovery of cannabinoid receptors. Biochem. Soc. Trans., 26, 267-272.
28. 1 receptors in guinea-pig small intestine. Br. J. Pharmacol., 118, 2199-2205.
29. 9-tetrahydrocannabinol and antagonist activity of cannabidiol on rat brain cannabinoid receptors. Life Sci., 63, PL1-PL6.
30. 2-adrenoceptor agonists on gastrointestinal transit during croton oil-induced intestinal inflammation. Br. J. Pharmacol., 119, 1649-1655.
31. RINALDI-CARMONA, M., BARTH, F., HEAULME, M., ALFONSO, R., SHIRE, D., CONGY, C., SOBRIE', P., BRELIERE, J.-C. & LE FUR, G. (1995). Biochemical and pharmacological characterization of SR141716A, the first potent and selective brain cannabinoid receptor antagonist. Life Sci., 56, 1941-1947.
32. 2 cannabinoid receptors. J. Pharmacol. Exp. Ther., 284, 644-650.
33. SCHIRGI-DEGEN, A. & BEUBLER, E. (1995). Significance of nitric oxide in the stimulation of intestinal fluid absorption in the rat jejunum in vivo. Br. J. Pharmacol., 114, 13-18.
34. SHOOK, J.E. & BURKS, T.F. (1989). Psychoactive cannabinoids reduce gastrointestinal propulsion and motility in rodents. J. Pharmacol. Exp. Ther., 249, 444-449.
35. STELLA, N., SCHWEITZER, P. & PIOMELLI, D. (1997). A second endogenous cannabinoid that modulates long-term potentiation. Nature, 388, 773-778.
36. TALLARIDA, R.J. & MURRAY, R.B. (1986). Manual of Pharmacological Calculations with Computer Programs. New York: Springer-Verlag.